Therapeutic benefits of CD90‐negative cardiac stromal cells in rats with a 30‐day chronic infarct

Publisher： John Wiley & Sons Inc

E-ISSN： 1582-4934|22|3|1984-1991

ISSN： 1582-1838

Source： Journal of Cellular and Molecular Medicine, Vol.22, Iss.3, 2018-03, pp. : 1984-1991

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Brentuximab vedotin exerts profound antiproliferative and pro‐apoptotic efficacy in CD30‐positive as well as cocultured CD30‐negative germ cell tumour cell lines

By  

Journal of Cellular and Molecular Medicine, Vol. 22, Iss. 1, 2018-01 ,pp. : 568-575

John Wiley & Sons Inc

Access to resources Recommend Favorite

Invasive surgery reduces infarct size and preserves cardiac function in a porcine model of myocardial infarction

By  

Journal of Cellular and Molecular Medicine, Vol. 19, Iss. 11, 2015-11 ,pp. : 2655-2663

John Wiley & Sons Inc

Access to resources Recommend Favorite

Chronic kidney disease with comorbid cardiac dysfunction exacerbates cardiac and renal damage

By  

Journal of Cellular and Molecular Medicine, Vol. 22, Iss. 1, 2018-01 ,pp. : 628-645

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prokineticin 1 is up‐regulated by insulin in decidualizing human endometrial stromal cells

By  

Journal of Cellular and Molecular Medicine, Vol. 22, Iss. 1, 2018-01 ,pp. : 163-172

John Wiley & Sons Inc

Access to resources Recommend Favorite

Autophagy and mitochondrial remodelling in mouse mesenchymal stromal cells challenged with Staphylococcus epidermidis

By  

Journal of Cellular and Molecular Medicine, Vol. 19, Iss. 5, 2015-05 ,pp. : 1133-1150

John Wiley & Sons Inc

Access to resources Recommend Favorite